Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
Frequently asked questions
What sector does Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) operate in?
Shanghai Haoyuan Chemexpress Co. Ltd. A belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) current stock price?
As of the latest data, Shanghai Haoyuan Chemexpress Co. Ltd. A stock price is CN¥97.60, with a previous close of CN¥100.48. Shanghai Haoyuan Chemexpress Co. Ltd. A lost -CN¥2.88 in the last trading session, representing a -2.87% loss.
What is Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) current market capitalization?
Shanghai Haoyuan Chemexpress Co. Ltd. A market cap is approximately 20.81 billion.
What is Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.15, and the forward EPS is CN¥2.15.
What is Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) Price-to-Earnings (P/E) ratio?
Shanghai Haoyuan Chemexpress Co. Ltd. A current P/E ratio is 84.87, with a forward P/E of 45.4.
Does Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) pay dividends?
Yes. Shanghai Haoyuan Chemexpress Co. Ltd. A pays semiannual dividends with an annualized yield of 0.18% and an estimated annual payout of CN¥0.18 per share.
When is the next ex-dividend date for Shanghai Haoyuan Chemexpress Co. Ltd. A (688131)?
The next ex-dividend date is scheduled for September 21, 2026.
What is Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) beta (volatility) score?
Shanghai Haoyuan Chemexpress Co. Ltd. A has a beta of 0.613, indicating lower volatility than the overall market.